¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"functional terminal innervation ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • extraction ratio
    ÃßÃâ·ü
  • fetal death ratio
    žƻç¸Áºñ
  • gyromagnetic ratio
    ÀÚ±âȸÀüºñ
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²
  • heart lung ratio
    ½ÉÆóºñ
  • hydrodynamic ratio
    ¼ö·ÂÇкñÀ², À¯Ã¼¿ªÇкñÀ²
  • inverse-ratio ventilation
    ¿ªºñȯ±â
  • inspiratory expiratory ratio
    µé¼û³¯¼ûºñÀ², Èí±âÈ£±âºñÀ²
  • insulin-to-glucose ratio
    Àν¶¸°´ëÆ÷µµ´çºñ
  • International Normalized Ratio
    ±¹Á¦Ç¥ÁØÈ­ºñÀ²
  • M:E ratio
    M:EºñÀ²
  • mixing water ratio
    ¹°È¥ÇÕºñ
  • monocyte lymphocyte ratio
    ´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • terminal ventricle
    ô¼ö³ú½Ç
  • terminal villus
    Á¾¸»À¶¸ð
  • terminal respiratory unit
    Á¾¸»È£Èí´ÜÀ§
  • A-G ratio
    (¢¡albumin-globulin ratio) ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • abortion ratio
    À¯»êºñ
  • age-dependency ratio
    ¿¬·ÉºÎ¾çºñ
  • air entrainment ratio
    °ø±âÀ¯ÀÔ·ü
  • air pollution ratio
    ´ë±â¿À¿°·ü
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×Ç÷ûºñ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • arm ratio
    µÎÆÈºñ
  • axial ratio
    Ãàºñ
  • benefit/risk ratio
    À¯ÀÍÀ¯ÇغñÀ²
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×´¢¼ÒÁú¼ÒÅ©·¹¾ÆÆ¼´Ñºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • functional congestion
    ±â´ÉÀû ¿ïÇ÷.
  • functional dead space
    ±â´ÉÀû »ç°­ (¡­ÞÝË·).
  • functional deafness
    ±â´É(¼º) ³­Ã»
  • functional deficiency
    ±â´É°áÇÌ
  • functional derangements
    ±â´ÉÀå¾Ö(ÀÌ»ó)
  • functional disorder
    ±â´É¼º Àå¾Ö.
  • functional dysmenorrhea
    ±â´É¼º ¿ù°æ°ï¶õ(Áõ)(¡­êÅÌèÍÝÑññø).
  • functional dyspepsia
    ±â´É¼º ¼ÒÈ­ºÒ·®.
  • functional endoscopic sinus surgery
    ±â´É(Àû) ³»½Ã°æ ºÎºñµ¿¼ö¼ú
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ).
  • functional hallucination See hallucination
    ±â´ÉÀû ȯ°¢(ѦÒöîÜü³ÊÆ).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • functional hypogammaglobulinemia
    ±â´É¼º Àú°¨¸¶±Û·ÎºÒ¸°Ç÷Áõ
  • functional hypoglycemia
    ±â´ÉÀû ÀúÇ÷´ç.
  • functional ileus
    ±â´É¼º ÀÏ·¹¿ì½º, ±â´É¼º ÀåÆó»ö.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • terminal portion
    Á¾¸»ºÎºÐ
  • terminal respiratory units
    Á¾¸»È£Èí´ÜÀ§(ðûØÇû¼ýåÓ¤êÈ).
  • terminal resporatory unit
    ¸»´ÜÈ£Èí´ÜÀ§
  • terminal stage
    ¸»±â(ØÇÑ¢).
  • terminal sulcus
    ºÐ°è±¸
  • terminal sulcus
    ºÐ°è°í¶û, ºÐ°è¸ª.
  • terminal sulcus
    ºÐ°è°í¶û
  • terminal ventricle
    Á¾¸»³ú½Ç
  • terminal villi
    Á¾¸»À¶¸ð
  • terminal villus
    Á¾¸»À¶¸ð
  • tubular terminal part
    ´ë·ÕÁ¾¸»ºÎºÐ
  • tubular terminal portion
    ´ë·ÕÁ¾¸»ºÎÀ§
  • tubuloalveolar terminal part
    ´ë·Õ²Ê¸®Á¾¸»ºÎºÐ
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • functional albuminuria
    ±â´É¼º ´Ü¹é´¢.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
AT abdominal thrusts; achievement test; Achilles tendon; Achard-Thiers [syndrome]; adaptive thermogenes...
Ct carboxyl terminal
CTW central terminal of Wilson; combined testicular weight
DNTT terminal deoxynucleotidyltransferase
ERT esophageal radionuclide transit; estrogen replacement therapy; examination room terminal; external r...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
FCT Functional communication training
FD Functional dyspepsia
fMR Functional magnetic resonance
FMS Functional magnetic stimulation
VmaxFRC Maximal flow at functional residual capacity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • functional record
    ±â´É ±â·Ï
  • functional regeneration
    ±â´ÉÀû Àç»ý
  • functional residual capacity
    ±â´ÉÀû ÀÜ·ù ¿ë·®, ±â´ÉÀû Àܱⷮ
  • functional shorting
    ±â´ÉÀû ´ÜÃà
  • functional stop
    ±â´ÉÀû ¸ØÃã ÅÎ
  • functional temporomandibular joint disturbance
    ±â´ÉÀû ÃøµÎÇϾǰüÀý Àå¾Ö
  • functional transcranial radiograph
    ±â´ÉÀû ȾµÎ°³ ¹æ»ç¼± »çÁø
  • functional wear
    ±â´ÉÀû ¸¶¸ð
  • optimum functional occlusion
    ±â´ÉÀû ÃÖÀû ±³ÇÕ
  • polymorphonuclear neutrophils functional disorder
    ´ÙÇüÇ٠ȣÁõ±¸ ±â´É ÀÌ»ó
  • registration of functional form
    ±â´É ÇüÅ Àαâ
  • sagittal plane functional movement
    ½Ã»ó¸é ±â´É ¿îµ¿
  • securing-method of functional occlusal position
    ±â´É ±³ÇÕÀ§ 䵿¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
gyromagnetic ratio In nuclear magnetic resonance, the ratio of the magnetic dipole moment of the nucleus to the nuclear spin angular momentum; the gyromagnetic ratio is a unique value for each type of nucleus.
Synonym: magnetogyric ratio.
(05 Mar 2000)
molecular weight ratio The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
P/O ratio A measure of oxidative phosphorylation; the ratio of phosphate radicals esterified (forming adenosine 5'-triphosphate from adenosine 5'-diphosphate) to atoms of oxygen consumed by mitochondria; normally, the ratio is 3 (starting from NADH).
Synonym: P/O quotient.
(05 Mar 2000)
hand ratio The ratio of the length of the hand (measured on the dorsum from the styloid process of the ulna to the tip of the third finger) to the width across the knuckles.
(05 Mar 2000)
segregation ratio In genetics, the proportion of progeny of a particular genotype or phenotype from actual matings of specified genotypes. The test of a Mendelian hypothesis is the comparison of the segregation rate with the Mendelian rate.
(05 Mar 2000)
sex ratio The number of males per 100 females.
(12 Dec 1998)
signal-to-noise ratio <microscopy> Also sometimes used as an abbreviation for serial number, can be somewhat confusing in the case of electronic equipment.
(05 Aug 1998)
split ratio The fraction of the cells in a fully grown culture of animal cells that should be used to start a subsequent culture. Minimum may be dictated by medium inadequacies that result in poor growth of some cells at high dilution.
(18 Nov 1997)
standardised mortality ratio The ratio of the number of events observed in a population to the number that would be expected if the population had the same distribution as a standard or reference population.
(05 Mar 2000)
nuclear-cytoplasmic ratio Ratio of volume of nucleus to volume of cytoplasm, fairly constant for a particular cell type and usually increased in malignant neoplasms.
(05 Mar 2000)
nucleolar-nuclear ratio Ratio of volume of nucleolus to volume of nucleus, usually increased in malignant neoplasms.
(05 Mar 2000)
nutritive ratio The ratio or proportion of digestible protein to digestible non-nitrogenous nutrients in a ration for livestock.
(05 Mar 2000)
systolic/diastolic ratio A calculation from pulsed Doppler ultrasound determinations of blood flow velocities that reflects intrinsic resistance in an arterial blood vessel.
(05 Mar 2000)
international normalised ratio System established by the world health organization and the international committee on thrombosis and haemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardised using the international sensitivity index for the particular test reagent/instrument combination used.
(12 Dec 1998)
IRI/G ratio The ratio of immunoreactive insulin to serum or plasma glucose; in hypoglycaemic states a ratio of less than 0.3 is usual with the exception of the hypoglycaemia due to insulinoma, where the ratio is often higher than 0.3.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á